翰思艾泰生物医药科技（武汉）股份有限公司（翰思艾泰-B，03378）于2026年3月5日发布截至2026年2月28日的股份变动月报表。公告显示，公司报告期内已发行普通股数量为136,218,830股，面值每股人民币0.1元，总股本为人民币13,621,883元，与上月底保持一致。
报告期内未出现新增发行、购回、注销或库藏股等股份变动，亦无股份期权、股权激励计划或可换股票据的相关变动事宜。公司确认其已符合香港联交所对公众持股量的要求，并表示遵守香港联交所《上市规则》及其他法律法规的规定。本次月报由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.